LINEZOLID | A078061 | TEVA PHARMACEUTICALS USA
Total Spending
$23.3M
Total Claims
114,653
Beneficiaries
88,286
Avg Cost/Unit
$9.55
Spending Trend
Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.
22 active API suppliers hold Drug Master Files for this ingredient.
Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.
| Date | Submission | Document |
|---|---|---|
| May 20, 2015 | ORIG -1 | View Letter (PDF) |
Source: Drugs@FDA application documents.
No patent or exclusivity listings for this strength.